Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27610491 | 0.76 | — | — | |
| SCHEMBL27463576 | 0.76 | — | — | |
| SCHEMBL11767856 | 0.75 | ALOX15 (0.37) | MEN1CYP3A4ALOX15KMT2AMAPT | |
| SCHEMBL11767852 | 0.75 | ALOX15 (0.37) | MEN1CYP3A4ALOX15KMT2AMAPT | |
| SCHEMBL1660622 | 0.75 | MEN1 (0.37) | MEN1CYP3A4ALOX15KMT2AMAPT | |
| SCHEMBL1660623 | 0.75 | MEN1 (0.37) | MEN1CYP3A4ALOX15KMT2AMAPT | |
| SCHEMBL4306769 | 0.74 | ALOX15 (0.37) | ALOX15KMT2A | |
| SCHEMBL4306767 | 0.74 | ALOX15 (0.37) | ALOX15KMT2A | |
| SCHEMBL27884828 | 0.74 | ALOX15 (0.37) | ALOX15KMT2A | |
| SCHEMBL790399 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150105460-A1 | LABDANE DITERPENOID COMPOUNDS, SEMEN BIOTAE EXTRACT, AND PREPARATION METHOD AND USE THEREOF | SU WEIWEI (CN) | 2015-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150105460-A1 | LABDANE DITERPENOID COMPOUNDS, SEMEN BIOTAE EXTRACT, AND PREPARATION METHOD AND USE THEREOF | NASP, GSDMD, DRD5 | MEN1 821/4885CYP3A4 989/4885ALOX15 16/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.